BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4808855)

  • 21. Duration of circulating and secretory antibody and cell-mediated immunity following immunization.
    Waldman RH; Ganguly R
    Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged rubella IgM antibody response.
    Stallman ND; Allan BC; Sutherland CJ
    Med J Aust; 1974 Oct; 2(17):629-31. PubMed ID: 4444610
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro correlates of cell-mediated immunity in human tonsils after natural or induced Rubella virus infection.
    Morag A; Morag B; Bernstein JM; Beutner K; Ogra PL
    J Infect Dis; 1975 Apr; 131(4):409-16. PubMed ID: 1117197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental infection with rubella virus. I. Acquired and congenital infection in rats.
    Avila L; Rawls WE; Dent PB
    J Infect Dis; 1972 Dec; 126(6):585-92. PubMed ID: 4664115
    [No Abstract]   [Full Text] [Related]  

  • 25. Rubella immunity in Nigerian children.
    Odelola HA; Familusi JB; Akinyemi A
    Trans R Soc Trop Med Hyg; 1980; 74(6):743-4. PubMed ID: 7210126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of chromosomal breakage in congenital rubella.
    Wolman SR; McMorrow LE; Ziring PR; Cooper LZ
    Pediatrics; 1973 Aug; 52(2):213-20. PubMed ID: 4721443
    [No Abstract]   [Full Text] [Related]  

  • 27. Impaired in vitro cell-mediated immunity to rubella virus during pregnancy.
    Thong YH; Steele RW; Vincent MM; Hensen SA; Bellanti JA
    N Engl J Med; 1973 Sep; 289(12):604-6. PubMed ID: 4269242
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunity status of 2 Chilean female populations against rubella].
    Ramírez E; Espiñeira E; Sánchez G
    Rev Med Chil; 1990 May; 118(5):495-9. PubMed ID: 2293267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rubella-specific immune complexes after congenital infection and vaccination.
    Coyle PK; Wolinsky JS; Buimovici-Klein E; Moucha R; Cooper LZ
    Infect Immun; 1982 May; 36(2):498-503. PubMed ID: 7085069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
    Naficy K; Nategh R; Ahangary S; Mohsenin H
    Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902
    [No Abstract]   [Full Text] [Related]  

  • 31. Determination of immune status in patients with low antibody titers for rubella virus.
    Fayram SL; Akin S; Aarnaes SL; Peterson EM; de la Maza LM
    J Clin Microbiol; 1987 Jan; 25(1):178-80. PubMed ID: 3539991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rubella immunity: comparison of hemagglutination inhibition and radioimmunoassay antibody methods.
    Harris RE; Smith KO; Gehle WD; Dupuy HJ
    Obstet Gynecol; 1980 May; 55(5):603-7. PubMed ID: 7366918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of rubella immunity and resistance to infection.
    Davis WJ; Larson HE; Simsarian JP; Parkman PD; Meyer HM
    JAMA; 1971 Jan; 215(4):600-8. PubMed ID: 5107436
    [No Abstract]   [Full Text] [Related]  

  • 34. [Rubella HI antibody titer prior to and after the epidemic in the same group and other viral infection in rubella epidemic (author's transl)].
    Watanabe N
    Kansenshogaku Zasshi; 1979 Mar; 53(3):115-20. PubMed ID: 112196
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
    Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
    N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
    [No Abstract]   [Full Text] [Related]  

  • 36. Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures.
    Vesikari T; Kanra GY; Buimovici-Klein E; Cooper LZ
    Clin Exp Immunol; 1975 Jan; 19(1):33-43. PubMed ID: 1081925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunodeficiency with congenital rubella.
    Ribon A; Wasserman E
    Ann Allergy; 1973 Jan; 32(1):35-40. PubMed ID: 4128462
    [No Abstract]   [Full Text] [Related]  

  • 38. Persistence of vaccine-induced immune responses to rubella: comparison with natural infection.
    Horstmann DM; Schluederberg A; Emmons JE; Evans BK; Randolph MF; Andiman WA
    Rev Infect Dis; 1985; 7 Suppl 1():S80-5. PubMed ID: 4001740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rubella antibody titres, rubella vaccination, and the obstetrician.
    Giles PF; Mackay-Scollay EM; Christiansen K
    Aust N Z J Obstet Gynaecol; 1973 May; 13(2):65-71. PubMed ID: 4518717
    [No Abstract]   [Full Text] [Related]  

  • 40. Experimental active and passive immunization against rubella.
    Budai J; Tóth M; Melis L
    Acta Paediatr Acad Sci Hung; 1970; 11(3):209-17. PubMed ID: 4111953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.